Real-world experience of circulating tumor DNA testing in resectable colorectal cancer: a Japanese single-institution observational study
{{output}}
Background: Assessment of molecular residual disease (MRD) using circulating tumor DNA (ctDNA) is a powerful prognostic tool for detecting postoperative recurrence in colorectal cancer (CRC). However, ctDNA-based MRD testing has ... ...
